Cargando…
Hemostatic alterations in COVID-19
Autores principales: | Peyvandi, Flora, Artoni, Andrea, Novembrino, Cristina, Aliberti, Stefano, Panigada, Mauro, Boscarino, Marco, Gualtierotti, Roberta, Rossi, Federica, Palla, Roberta, Martinelli, Ida, Grasselli, Giacomo, Blasi, Francesco, Tripodi, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094101/ https://www.ncbi.nlm.nih.gov/pubmed/32855280 http://dx.doi.org/10.3324/haematol.2020.262634 |
Ejemplares similares
-
Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
por: Panigada, Mauro, et al.
Publicado: (2020) -
Complement activation in patients with COVID-19: A novel therapeutic target
por: Cugno, Massimo, et al.
Publicado: (2020) -
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19
por: Martinelli, Ida, et al.
Publicado: (2021) -
No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2
por: Peyvandi, Flora, et al.
Publicado: (2021) -
Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)